Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), Obesity, Research
←Cannonball with Wesley Morris: Beyoncé Isn’t Giving Up on America
The Trump-Backed Federal Budget Threatens Black Economic Progress. Here’s How Black Communities Can Reclaim Their Power→

More posts

  • John Leeson Dies: Actor Who Voiced Iconic Role In ‘Doctor Who’ Was 83

  • Lachlan Murdoch Notes Fox News “Viewer Fatigue” Around Midterms Amid Year-Over-Year Viewership Declines

  • ‘The Man With The Bag’ Trailer: Arnold Schwarzenegger Stars As Santa In Amazon MGM’s Christmas Heist Caper

  • Springsteen backs El-Sayed: ‘He’s a fighter for our American Constitution’

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube